Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
Clinical trial NCT02694263 · COMPLETED
Trial details
- NCT number
- NCT02694263
- Sponsor
- University of Leicester
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-09-13
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.